News
ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today ...
ViiV & MPP extend voluntary licensing long-acting injectable HIV treatment, Indian pharma to benefit
ViiV & MPP extend voluntary licensing long-acting injectable HIV treatment, Indian pharma to benefit: Our Bureau, Bengaluru Tuesday, July 15, 2025, 12:45 Hrs [IST] ViiV Healthcare ...
Plaintiffs allege that CRISP and its subsidiary willfully infringed on patented technology by launching a copycat product after terminating a long-standing licensing agreement.
Sun recieved approval from the US Food and Drug Administration for Leqselvi in July 2024. Soon after the regulator’s approval ...
The VDP Pool from AccessAdvance has successfully attracted a group of licensees/licensors including ByteDance, Kuaishou, NTT ...
After resolving a patent dispute with Incyte, Sun Pharma has officially launched its JAK inhibitor Leqselvi in the U.S. | Sun ...
According to a survey conducted by the Organization for Economic Co-operation and Development, as early as 2004, 60% of firms and companies reported an increase in inward and outward patent licensing.
A rankings chart provides patent-and-licensing data from 154 colleges and universities.
January 15, 2006 (Vol. 26, No. 2) Threat of Avian Flu Pandemic Has Countries & Pharma Firms Exploring Manufacturing Options If profits are the carrot, compulsory licensing is the stick in the ...
Add to Calendar 06/27/2025 8:25 AM America/New_York The Future of Patent Dealmaking, Monetization and Licensing * As the result of patent skepticism among policy makers and jurists in the United ...
It is crucial that patent licensing agreements be properly structured to ensure that the intention of the parties is clearly described and that the structure of the agreement comports with the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results